Dual inhibition of the MAPK pathway helps boost immune responses to checkpoint inhibitors in patients with previously treated BRAFV600E-mutated metastatic colorectal cancer.

©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.